Avanos Medical (AVNS) Shareholder's Equity Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Avanos Medical | 1.17 Bn | 1.10 Bn | 94.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 199.95% |
| Dec 31, 2025 | -15.53% |
| Sep 30, 2025 | -14.93% |
| Jun 30, 2025 | -26.40% |
| Mar 31, 2025 | -19.90% |
| Dec 31, 2024 | -27.61% |
| Sep 30, 2024 | -0.99% |
| Jun 30, 2024 | -30.87% |
| Mar 31, 2024 | -31.06% |
| Dec 31, 2023 | -0.69% |
| Sep 30, 2023 | -1.78% |
| Jun 30, 2023 | -97.15% |
| Mar 31, 2023 | 12.61% |
| Dec 31, 2022 | 0.48% |
| Sep 30, 2022 | -0.09% |
| Jun 30, 2022 | 477.30% |
| Mar 31, 2022 | 101.80% |
| Dec 31, 2021 | -0.69% |
| Sep 30, 2021 | -0.86% |
| Jun 30, 2021 | -6.01% |
| Mar 31, 2021 | -6.88% |
| Dec 31, 2020 | 1.26% |
| Sep 30, 2020 | 2.99% |
| Jun 30, 2020 | -26.16% |
| Mar 31, 2020 | -26.86% |
| Dec 31, 2019 | 4.90% |
| Sep 30, 2019 | 4.77% |
| Jun 30, 2019 | -26.16% |
| Mar 31, 2019 | -30.91% |
| Dec 31, 2018 | 7.12% |
| Sep 30, 2018 | 7.69% |
| Jun 30, 2018 | 1.00% |
| Mar 31, 2018 | 0.99% |
| Dec 31, 2017 | -6.59% |
| Sep 30, 2017 | -17.19% |
| Dec 31, 2016 | -19.06% |
| Sep 30, 2016 | -19.50% |